If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksODX.L Regulatory News (ODX)

  • There is currently no data for ODX

Agreement with Super Religare Laboratories

15 Oct 2012 07:00

RNS Number : 6503O
Omega Diagnostics Group PLC
15 October 2012
 



  

Omega Diagnostics Group PLC

("Omega" or the "Company")

 

Agreement with Super Religare Laboratories ("SRL"), India

 

Omega, the medical diagnostics company focussed on allergy, food intolerance and infectious disease, announces that, Omega Dx (Asia) Pvt Ltd, its fully owned subsidiary in India, has signed an exclusive agreement with SRL for the distribution of Food Detective® throughout India. SRL is a leading pioneer of medical diagnostics in India with a network of over 200 laboratories and over 1,300 collection centres.

 

Food Detective® is the Company's consumer facing product which can test a person's reaction against 59 common food types. The product has already been approved for use in India and has been specifically adapted for the Indian market. The agreement will run for an initial period of one year but is extendable thereafter and has minimum performance targets that SRL are required to meet.

 

Andrew Shepherd, Chief Executive of Omega added: "We are very pleased to be working with SRL, the most prominent laboratory network in India. Food Detective® has great potential in India where there is increasing awareness around health and well-being amongst a growing middle class population with rising levels of disposable income."

 

Dr Sanjeev K Chaudhry, MD of SRL Ltd said, "It has long been known that intake of certain foods can have profound effects on the physical and mental well being of susceptible individuals. This is even more evident in today's world with the huge variety of processed foods we now consume. Appearance of symptoms is often delayed and it can be difficult to identify the food which causes the symptoms. Launch of a simple and convenient Food Detective™ Test in India will prove to be a boon for people suffering from lifestyle related food reactivities."

 

Sanjeev Vashishta, CEO of SRL added: "We are pleased to partner with leading UK company Omega Diagnostics for FOOD DETECTIVE TEST. The addition of this test will complement and strengthen our food allergies/intolerance diagnostics portfolio in India thereby firmly establishing SRL as leader in this niche segment."

 

Contacts:

 

Omega Diagnostics Group PLC

Tel: 01259 763 030

Andrew Shepherd, Chief Executive

Kieron Harbinson, Group Finance Director

Jag Grewal, Group Sales and Marketing Director

www.omegadiagnostics.com

Seymour Pierce Limited

Tel: 020 7107 8000

www.seymourpierce.com

Mark Percy (Corporate Finance)

David Banks / Katie Ratner (Corporate Broking)

Walbrook PR Limited

Paul McManus

Tel: 020 7933 8787

Mob: 07980 541 893

paul.mcmanus@walbrookpr.com

 

Information on SRL Diagnostics - Global Diagnostics network

SRL Diagnostics (SRL) is the veritable pioneer of medical diagnostics in India. The only diagnostics network in India to have 12 Reference Laboratories, 4 centres of excellence, over 200 network laboratories, 19 radiology/imaging centres, and a footprint spanning over 1300 Collection Centres. SRL has been imbued with a mission to deliver Gold Standard Diagnostic services, both in the field of Laboratory Medicine and non-pathology services, including Radiology and hi-end Imaging services.

 

SRL continues to revolutionalise diagnostic services in India by ushering in the most specialised technologies, and innovative services. Today its operations extend to the Gulf, North Africa, SAARC countries, Europe etc and it handles over 12 million test samples every year. 

Its research and development division is ISO certified and recognized by the Government of India's Department of Scientific and Industrial Research. SRL's wide range of tests provides quality diagnostic, prognostic and monitoring services to other pathology labs, hospitals and patients. It also provides clinical research services by conducting Phase I- IV clinical trials for multinational and Indian pharmaceutical and biotechnological companies, thereby supporting their international regulatory submissions. 

 

www.srlworld.com 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGRBKQDPFBDDBKD
Date   Source Headline
6th Sep 20237:00 amRNSAGM Statement
1st Sep 202310:29 amRNSUpdate on proposed Share Reorganisation
31st Aug 20237:00 amRNSProposed Share Reorganisation Timetable
22nd Aug 20237:00 amRNSDirectorate Change
17th Aug 20237:00 amRNSBoard Appointment
15th Aug 20231:45 pmRNSDirector/PDMR Shareholding
14th Aug 20237:00 amRNSPosting of Annual Report and confirmation of AGM
3rd Aug 20237:00 amRNSFinal Results
27th Jul 20237:00 amRNSNotice of Results
26th Jul 20232:10 pmRNSHolding(s) in Company
6th Jun 202311:19 amRNSHolding(s) in Company
5th Jun 20234:51 pmRNSHolding(s) in Company
2nd Jun 20232:45 pmRNSHolding(s) in Company
22nd May 20235:33 pmRNSHolding(s) in Company
10th May 20237:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
9th May 20233:42 pmRNSDirector/PDMR Shareholding
21st Apr 20239:48 amRNSHolding(s) in Company
19th Apr 20239:31 amRNSHolding(s) in Company
17th Apr 20237:00 amRNSTrading Update
22nd Mar 20235:57 pmRNSBlock Listing Six Monthly Return
22nd Mar 20233:00 pmRNSHolding(s) in Company
6th Mar 20232:31 pmRNSHolding(s) in Company
27th Jan 20233:03 pmRNSHolding(s) in Company
27th Jan 20239:36 amRNSDirector/PDMR Shareholding
18th Jan 20237:00 amRNSTrading update
16th Jan 202310:56 amRNSHolding(s) in Company
6th Jan 20237:00 amRNSUS expansion update
3rd Jan 202312:34 pmRNSHolding(s) in Company
13th Dec 20224:40 pmRNSSecond Price Monitoring Extn
13th Dec 20224:35 pmRNSPrice Monitoring Extension
13th Dec 202212:01 pmRNSHolding(s) in Company
30th Nov 20229:35 amRNSHolding(s) in Company
25th Nov 20227:00 amRNSReceipt of deferred consideration
24th Nov 20227:00 amRNSHalf-year Report
23rd Nov 20224:41 pmRNSSecond Price Monitoring Extn
23rd Nov 20224:36 pmRNSPrice Monitoring Extension
23rd Nov 20222:05 pmRNSSecond Price Monitoring Extn
23rd Nov 20222:00 pmRNSPrice Monitoring Extension
18th Nov 202212:09 pmRNSHolding(s) in Company
16th Nov 20222:06 pmRNSSecond Price Monitoring Extn
16th Nov 20222:00 pmRNSPrice Monitoring Extension
15th Nov 20227:00 amRNSConfirmation of Results and Investor Presentation
14th Nov 20227:00 amRNSPartnership agreement with Software Provider
8th Nov 20229:04 amRNSLaunch of new all-employee share incentive plan
26th Oct 20222:50 pmRNSResult of AGM
26th Oct 20227:00 amRNSAGM Statement and Notice of Results
11th Oct 20227:00 amRNSScientific Director to present at FIDHC
5th Oct 20227:00 amRNSPositive WHO data received for VISITECT® CD4 test
27th Sep 20227:00 amRNSPosting of Annual Report and confirmation of AGM
20th Sep 202212:05 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.